Thursday, April 25, 2024

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

New way to increase antimicrobial sensitivity discovered

New way to increase antimicrobial sensitivity discovered

Scientists have discovered a new way to make bacteria more sensitive to antibiotics in a bid to tackle the antibiotic resistance crisis. In a new...
Reducing wound bioburden with antimicrobial dressings

Reducing wound bioburden with antimicrobial dressings

HEQ examines the role of dressings with antimicrobial properties in treating and preventing wound infection. The increased prevalence of antimicrobial dressings in wound care can...
Reduce esketamine price to manage treatment-resistant depression 

Reduce esketamine price to manage treatment-resistant depression 

Researchers are hoping their new paper will encourage policymakers, insurers, and healthcare leaders to work to reduce the price of esketamine nasal spray to...
Innovative antibiotics to be available for UK patients in world-first scheme

Innovative antibiotics to be available for UK patients in world-first scheme

A new scheme that starts this week is aiming to provide innovative antibiotics to NHS patients for the first time in almost 30 years...
Capture the Fracture aims for 25% reduction in osteoporosis fractures

Capture the Fracture aims for 25% reduction in osteoporosis fractures

UCB Amgen has today announced a collaboration with the International Osteoporosis Foundation (IOF) to support its Capture the Fracture® programme. The Capture the Fracture® programme...
Tetra Bio-Pharma: building business on healing potential of cannabinoids

Tetra Bio-Pharma: building business on healing cannabinoid medicines

Canada’s Tetra Bio-Pharma is on a path to become a world leader in the development of cannabinoid-derived medicines. Canada’s Tetra Bio-Pharma is on a path...
Taking biopharmaceutical vaccine candidates from research to clinical trial

Taking biopharmaceutical vaccine candidates from research to clinical trial

The Vaccine Development Department at Statens Serum Institut provides experience and expertise at each stage of the research and development process for biopharmaceutical vaccine...
Could ibogaine offer a revolutionary long-term solution to addiction?

Could ibogaine offer a revolutionary long-term solution to addiction?

Derived from the iboga plant, ibogaine is a psychoactive compound that could have huge potential as a long-term solution to addiction. ATAI Life Sciences...
New EU approved flu vaccine is designed to protect over 65’s

New EU approved flu vaccine is designed to protect over 65’s

The European Commission has given regulatory approval for the first adjuvanted quadrivalent influenza vaccine to become available across Europe and is designed to protect...
Senolytic drugs: can this antibiotic treat symptoms of ageing?

Senolytic drugs: can this antibiotic treat symptoms of ageing?

Professor Michael P Lisanti of the University of Salford highlights the potential applications of senolytic drugs in treating age-associated conditions. Professor Michael P Lisanti, Chair...
UK companies to supply drugs for major UK COVID-19 drugs trial

UK companies to supply drugs for major UK COVID-19 drugs trial

Four drugs have been announced as the first to be involved with a major COVID-19 drugs trial that will be testing their efficacy for...
A 500-day journey prescribing medicinal cannabis in Australia

A 500-day journey prescribing medicinal cannabis in Australia

Donielle Paul BSN, RN follows Dr Ben Jansen along his 500-day journey prescribing medicinal cannabis in Australia. Dr Ben Jansen’s mission is solid: ‘to do...
WHO: reducing disease inequality with vaccine funding

WHO: reducing disease inequality with vaccine funding

The World Health Organization has welcomed crucial new funding for vaccines across the globe that it says will help in the fight against COVID-19,...
Could arketamine provide breakthrough therapy for depression?

Could arketamine be a breakthrough therapy for depression?

Clinical trials are being carried out to test the efficacy of arketamine as therapy for depression, with the aim of offering an alternative to...
Coronavirus Global Response campaign aims for affordable vaccine for all

Coronavirus Global Response campaign aims for affordable vaccine for all

The European Commission’s Coronavirus Global Response campaign has teamed up with Global Citizen to launch the next phase of the campaign that aims to...
Drug combination shows promise for treating COVID-19

Drug combination shows promise for treating COVID-19

New findings have shown that a triple antiviral drug combination holds promise for the treatment of COVID-19. Results from a randomised trial for treating COVID-19...
Discover how sample pooling can increase coronavirus testing capacity

Discover how sample pooling can increase coronavirus testing capacity

A team of scientists in Germany have developed a new procedure that will help increase coronavirus testing capacity. The development will help to increase coronavirus...
Protection against deadly, preventable diseases through European Immunisation Week

Protection against deadly, preventable diseases through European Immunisation Week

The EFN, as part of the Coalition for Vaccination, has launched a social media campaign during European Immunisation Week for nurses on vaccination for...
Drug candidate as potential therapy for cytokine release syndrome

Drug candidate as potential therapy for cytokine release syndrome

Preclinical proof of concept of PPP003 – a synthetic cannabinoid drug – has been put forward as potential therapy in the battle against COVID-19...
Vitamin supplements effective for fighting COVID-19

Vitamin supplements boost immune system in fight against COVID-19

New findings have confirmed the efficacy of dietary vitamin supplements – including vitamin C and vitamin D – in helping the immune system fight...

Featured Special Reports

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest